RBC Capital Maintains Outperform on CVS Health, Lowers Price Target to $108
Benzinga Newsdesk 12 hours ago
Analyst RatingsNewsPrice TargetHot
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
RBC Capital analyst Ben Hendrix maintains CVS Health (NYSE:CVS) with a Outperform and lowers the price target from $113 to $108.
RBC Capital analyst Ben Hendrix maintains CVS Health (NYSE:CVS) with a Outperform and lowers the price target from $113 to $108.
